Juan Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Juan Li has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Jianming Pei
Department of Physiology and Pathophysiology, National Key Discipline of Cell Biology, Fourth Military Medical University, No. 169 Changle West Road, Xi'an, Shaanxi 710032, China
6 shared publications Shumiao Zhang
Department of Physiology and Pathophysiology, National Key Discipline of Cell Biology, Fourth Military Medical University, No. 169 Changle West Road, Xi'an, Shaanxi 710032, China
6 shared publicationsNa Feng
Department of Physiology and Pathophysiology, National Key Discipline of Cell Biology, Fourth Military Medical University, No. 169 Changle West Road, Xi'an, Shaanxi 710032, China
5 shared publicationsXiaoming Gu
Department of Physiology and Pathophysiology, National Key Discipline of Cell Biology, Fourth Military Medical University, No. 169 Changle West Road, Xi'an, Shaanxi 710032, China
5 shared publicationsMin Zhang
Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China 410008
4 shared publicationsYali Liu
Department of Physiology and Pathophysiology, National Key Discipline of Cell Biology, Fourth Military Medical University, No. 169 Changle West Road, Xi'an, Shaanxi 710032, China
4 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 19, 1889911
The role of iNOS expression in cognitive impairment caused by lead exposure
Introduction: The effect of lead on spatial memory has been widely confirmed. Inducible nitric oxide synthase (iNOS) is a key enzyme in inflammatory responses that is significantly upregulated upon microglia activation. However, prior to this study, there has been no direct evidence that iNOS mediates excitatory toxicity. Methods: Sprague-Dawley rats (SD rats) were given ad libitum access to drinking water containing lead (Pb, 100 mg/L) from postnatal day (PND) 24 to 45, and each treatment group was paired with a supplement group that received either minocycline or S-methylisothiourea (SMT) via the corresponding administration route. Results: The results showed a significant difference in spatial memory and induction of hippocampal long-term potentiation (LTP) in the Pb exposure group when compared with controls. Simultaneously, Pb exposure also caused hippocampal microglia activation, iNOS expression, and neuronal apoptosis. Furthermore, the expression levels of syntaphilin (SNPH) and synaptophysin (Syp) were significantly decreased after lead exposure, along with glutamate accumulation in the cerebrospinal fluid (CSF). Further studies revealed that minocycline administration significantly inhibited microglia activation and subsequent iNOS expression, which was accompanied by a decrease in neuronal apoptosis, reversal of the expression of SNPH and Syp, reduction in glutamate accumulation, and significant improvement in the induction of synaptic plasticity and learning and memory ability. Furthermore, after SMT specifically inhibited the expression of iNOS, the observed effects were significantly reversed. Discussion: This study presents new evidence suggesting that the upregulated expression of microglial iNOS upon lead exposure may lead to lower expression levels of synaptic-associated proteins syntaphilin and synaptophysin. Subsequently, this may result in the accumulation of glutamate, neuronal damage, and synaptic plasticity impairment, ultimately leading to cognitive dysfunction.
- 11 November 2026
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 19, 1889911
Open AccessThe role of iNOS expression in cognitive impairment caused by lead exposure
Introduction: The effect of lead on spatial memory has been widely confirmed. Inducible nitric oxide synthase (iNOS) is a key enzyme in inflammatory responses that is significantly upregulated upon microglia activation. However, prior to this study, there has been no direct evidence that iNOS mediates excitatory toxicity. Methods: Sprague-Dawley rats (SD rats) were given ad libitum access to drinking water containing lead (Pb, 100 mg/L) from postnatal day (PND) 24 to 45, and each treatment group was paired with a supplement group that received either minocycline or S-methylisothiourea (SMT) via the corresponding administration route. Results: The results showed a significant difference in spatial memory and induction of hippocampal long-term potentiation (LTP) in the Pb exposure group when compared with controls. Simultaneously, Pb exposure also caused hippocampal microglia activation, iNOS expression, and neuronal apoptosis. Furthermore, the expression levels of syntaphilin (SNPH) and synaptophysin (Syp) were significantly decreased after lead exposure, along with glutamate accumulation in the cerebrospinal fluid (CSF). Further studies revealed that minocycline administration significantly inhibited microglia activation and subsequent iNOS expression, which was accompanied by a decrease in neuronal apoptosis, reversal of the expression of SNPH and Syp, reduction in glutamate accumulation, and significant improvement in the induction of synaptic plasticity and learning and memory ability. Furthermore, after SMT specifically inhibited the expression of iNOS, the observed effects were significantly reversed. Discussion: This study presents new evidence suggesting that the upregulated expression of microglial iNOS upon lead exposure may lead to lower expression levels of synaptic-associated proteins syntaphilin and synaptophysin. Subsequently, this may result in the accumulation of glutamate, neuronal damage, and synaptic plasticity impairment, ultimately leading to cognitive dysfunction.
- Open Access
- 1 March 2026
- Published by KEAI Publishing in Genes & Diseases
- Vol. 13 (2) , 101604
Macrophage κ-opioid receptor inhibits hypoxic pulmonary hypertension progression and right heart dysfunction via an SCD1-dependent anti-inflammatory response
We aimed to investigate the effects and mechanism(s) of macrophage κ-opioid receptor (κ-OR) on macrophage inflammatory response and hypoxic pulmonary hypertension (HPH). Macrophage κ-OR-deficient mice (κ-ORΔMac) and their wild-type control mice (κ-ORfl/fl) were subjected to HPH or control groups. Mice with HPH presented significantly decreased expression of κ-OR in peritoneal macrophages. Compared with the κ-ORfl/fl + control group, the κ-ORfl/fl + HPH group presented increased right ventricular pressure, pulmonary vascular remodeling, and right ventricular hypertrophy and dysfunction; infiltration of M1 macrophages around pulmonary vessels; increased NLRP3 protein expression; and the release of the inflammatory cytokines. Macrophage κ-OR deficiency significantly aggravated the phenomenon mentioned above. At the cellular level, macrophages with κ-OR deficiency also aggravated lipopolysaccharide-induced inflammation. In addition, administering the κ-OR-selective agonist U50,488H significantly inhibited the inflammatory response in macrophages. The co-culture experiments revealed that U50,488H-treated macrophages inhibited the proliferation of pulmonary artery smooth muscle cells. Furthermore, our RNA sequencing and western blotting results revealed that κ-OR increases stearoyl coenzyme desaturase 1 (SCD1) expression in macrophages. Macrophage κ-OR knockdown significantly decreased SCD1 expression both in the lung tissues of HPH mice and in cultured macrophages. Moreover, SCD1 overexpression significantly suppressed the inflammatory response in lipopolysaccharide-treated macrophages, whereas the pharmacological inhibition of SCD1 increased the response. These results demonstrated that macrophage κ-OR inhibited HPH and right heart dysfunction by up-regulating SCD1, which inhibited macrophage inflammatory responses and pulmonary artery smooth muscle cell proliferation. This study provides more evidence to support the potential therapeutic role of κ-OR activation in the treatment of HPH.
- 1 March 2026
- Published by KEAI Publishing in Genes & Diseases
- Vol. 13 (2) , 101604
Open AccessMacrophage κ-opioid receptor inhibits hypoxic pulmonary hypertension progression and right heart dysfunction via an SCD1-dependent anti-inflammatory response
We aimed to investigate the effects and mechanism(s) of macrophage κ-opioid receptor (κ-OR) on macrophage inflammatory response and hypoxic pulmonary hypertension (HPH). Macrophage κ-OR-deficient mice (κ-ORΔMac) and their wild-type control mice (κ-ORfl/fl) were subjected to HPH or control groups. Mice with HPH presented significantly decreased expression of κ-OR in peritoneal macrophages. Compared with the κ-ORfl/fl + control group, the κ-ORfl/fl + HPH group presented increased right ventricular pressure, pulmonary vascular remodeling, and right ventricular hypertrophy and dysfunction; infiltration of M1 macrophages around pulmonary vessels; increased NLRP3 protein expression; and the release of the inflammatory cytokines. Macrophage κ-OR deficiency significantly aggravated the phenomenon mentioned above. At the cellular level, macrophages with κ-OR deficiency also aggravated lipopolysaccharide-induced inflammation. In addition, administering the κ-OR-selective agonist U50,488H significantly inhibited the inflammatory response in macrophages. The co-culture experiments revealed that U50,488H-treated macrophages inhibited the proliferation of pulmonary artery smooth muscle cells. Furthermore, our RNA sequencing and western blotting results revealed that κ-OR increases stearoyl coenzyme desaturase 1 (SCD1) expression in macrophages. Macrophage κ-OR knockdown significantly decreased SCD1 expression both in the lung tissues of HPH mice and in cultured macrophages. Moreover, SCD1 overexpression significantly suppressed the inflammatory response in lipopolysaccharide-treated macrophages, whereas the pharmacological inhibition of SCD1 increased the response. These results demonstrated that macrophage κ-OR inhibited HPH and right heart dysfunction by up-regulating SCD1, which inhibited macrophage inflammatory responses and pulmonary artery smooth muscle cell proliferation. This study provides more evidence to support the potential therapeutic role of κ-OR activation in the treatment of HPH.
- 26 April 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 169, 110437
Compensative inter-module functional connectivity enhancement at the latter half of verbal fluency task in patients with temporal lobe epilepsy
- 26 April 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 169, 110437
Compensative inter-module functional connectivity enhancement at the latter half of verbal fluency task in patients with temporal lobe epilepsy
- Open Access
- 23 April 2025
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 31 (4) , e70298
Dynamic and Static Functional Gradient in Temporal Lobe Epilepsy With Hippocampal Sclerosis Versus Healthy Controls
Aims: The gradient captures the continuous transitions in connectivity, representing an intrinsic hierarchical architecture of the brain. Previous works hinted at the dynamics of the gradient but did not verify them. Cognitive impairment is a common comorbidity of temporal lobe epilepsy (TLE). Gradient techniques provide a framework that could promote the understanding of the neural correlations of cognitive decline. Methods: Thirty patients with TLE and hippocampal sclerosis and 29 matched healthy controls (HC) were investigated with verbal fluency task‐based functional MRI and gradient techniques. The correlation between task‐based activation/deactivation and healthy gradients, task‐based gradients, and dynamic features calculated with sliding window approaches was compared between HC and TLE. Results: The allegiance in the real data of HC and TLE was more widespread compared to static null models. TLE has lower dynamic recruitment of gradient, atypical activation‐gradient correlation, and contracted principal gradient. Correlation analysis proved that the reconfiguration of principal gradient did not drive the reorganization of activation. The atypical activation pattern and impaired recruitment were correlated with cognition scales in TLE. Discussion: The principal gradient is dynamic. TLE disrupted activation/deactivation patterns, the principal gradient, and the dynamics of the gradient, which were correlated with cognitive decline.
- 23 April 2025
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 31 (4) , e70298
Open AccessDynamic and Static Functional Gradient in Temporal Lobe Epilepsy With Hippocampal Sclerosis Versus Healthy Controls
Aims: The gradient captures the continuous transitions in connectivity, representing an intrinsic hierarchical architecture of the brain. Previous works hinted at the dynamics of the gradient but did not verify them. Cognitive impairment is a common comorbidity of temporal lobe epilepsy (TLE). Gradient techniques provide a framework that could promote the understanding of the neural correlations of cognitive decline. Methods: Thirty patients with TLE and hippocampal sclerosis and 29 matched healthy controls (HC) were investigated with verbal fluency task‐based functional MRI and gradient techniques. The correlation between task‐based activation/deactivation and healthy gradients, task‐based gradients, and dynamic features calculated with sliding window approaches was compared between HC and TLE. Results: The allegiance in the real data of HC and TLE was more widespread compared to static null models. TLE has lower dynamic recruitment of gradient, atypical activation‐gradient correlation, and contracted principal gradient. Correlation analysis proved that the reconfiguration of principal gradient did not drive the reorganization of activation. The atypical activation pattern and impaired recruitment were correlated with cognition scales in TLE. Discussion: The principal gradient is dynamic. TLE disrupted activation/deactivation patterns, the principal gradient, and the dynamics of the gradient, which were correlated with cognitive decline.
- 23 November 2024
- Published by Elsevier in European Journal of Pharmacology
- Vol. 986, 177152
Macrophage-specific κ-OR knockout exacerbates inflammation in hypoxic pulmonary hypertension
- 23 November 2024
- Published by Elsevier in European Journal of Pharmacology
- Vol. 986, 177152
Macrophage-specific κ-OR knockout exacerbates inflammation in hypoxic pulmonary hypertension
- Open Access
- 1 October 2023
- Published by Taylor & Francis in Vascular Health and Risk Management
- Vol. ume 19, 673-688
RGS5 as a Biomarker of Pericytes, Involvement in Vascular Remodeling and Pulmonary Arterial Hypertension
Introduction: Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by a sustained rise in mean pulmonary artery pressure. Pulmonary vascular remodeling serves an important role in PAH. Identifying a key driver gene to regulate vascular remodeling of the pulmonary microvasculature is critical for PAH management. Methods: Differentially expressed genes were identified using the Gene Expression Omnibus (GEO) GSE117261, GSE48149, GSE113439, GSE53408 and GSE16947 datasets. A co-expression network was constructed using weighted gene co-expression network analysis. Novel and key signatures of PAH were screened using four algorithms, including weighted gene co-expression network analysis, GEO2R analysis, support vector machines recursive feature elimination and robust rank aggregation rank analysis. Regulator of G-protein signaling 5 (RGS5), a pro-apoptotic/anti-proliferative protein, which regulate arterial tone and blood pressure in vascular smooth muscle cells. The expression of RGS5 was determined using reverse transcription-quantitative PCR (RT-qPCR) in PAH and normal mice. The location of RGS5 and pericytes was detected using immunofluorescence. Results: Compared with that in the normal group, RGS5 expression was upregulated in the PAH group based on GEO and RT-qPCR analyses. RGS5 expression in single cells was enriched in pericytes in single-cell RNA sequencing analysis. RGS5 co-localization with pericytes was detected in the pulmonary microvasculature of PAH. Conclusion: RGS5 regulates vascular remodeling of the pulmonary microvasculature and the occurrence of PAH through pericytes, which has provided novel ideas and strategies regarding the occurrence and innovative treatment of PAH.
- 1 October 2023
- Published by Taylor & Francis in Vascular Health and Risk Management
- Vol. ume 19, 673-688
Open AccessRGS5 as a Biomarker of Pericytes, Involvement in Vascular Remodeling and Pulmonary Arterial Hypertension
Introduction: Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by a sustained rise in mean pulmonary artery pressure. Pulmonary vascular remodeling serves an important role in PAH. Identifying a key driver gene to regulate vascular remodeling of the pulmonary microvasculature is critical for PAH management. Methods: Differentially expressed genes were identified using the Gene Expression Omnibus (GEO) GSE117261, GSE48149, GSE113439, GSE53408 and GSE16947 datasets. A co-expression network was constructed using weighted gene co-expression network analysis. Novel and key signatures of PAH were screened using four algorithms, including weighted gene co-expression network analysis, GEO2R analysis, support vector machines recursive feature elimination and robust rank aggregation rank analysis. Regulator of G-protein signaling 5 (RGS5), a pro-apoptotic/anti-proliferative protein, which regulate arterial tone and blood pressure in vascular smooth muscle cells. The expression of RGS5 was determined using reverse transcription-quantitative PCR (RT-qPCR) in PAH and normal mice. The location of RGS5 and pericytes was detected using immunofluorescence. Results: Compared with that in the normal group, RGS5 expression was upregulated in the PAH group based on GEO and RT-qPCR analyses. RGS5 expression in single cells was enriched in pericytes in single-cell RNA sequencing analysis. RGS5 co-localization with pericytes was detected in the pulmonary microvasculature of PAH. Conclusion: RGS5 regulates vascular remodeling of the pulmonary microvasculature and the occurrence of PAH through pericytes, which has provided novel ideas and strategies regarding the occurrence and innovative treatment of PAH.
- 28 April 2022
- Published by Wiley in Human Mutation
- Vol. 43 (7) , 940-949
DNAH14 variants are associated with neurodevelopmental disorders
Neurodevelopmental disorders (NDD) are complex and multifaceted diseases involving genetic and environmental sciences. Rapid developments in sequencing techniques have made it possible to identify new disease-causing genes. Our study aimed to identify novel genes associated with NDDs. Trio whole-exome sequencing was performed to evaluate potential NDD variants. We identified three unrelated patients with compound heterozygous DNAH14 variants. The detailed clinical information and genetic results of the recruited patients were obtained and systematically reviewed. Three compound heterozygous DNAH14 variants were identified as follows: c.6100C > T(p.Arg2034Ter) and c.5167A > G(p.Arg1723Gly), c.12640_12641delAA(p.Lys4214Valfs*7) and c.4811T > A(p.Leu1604Gln), andc.7615C > A(p.Pro2539Thr) and c.11578G > A(p.Gly3860Ser), including one nonsense, one frameshift, and four missense variants, which were not existent or with low minor allele frequencies based on the gnomAD database. The missense variants were assumed to be damaging or probably damaging by using multiple bioinformatics tools. Four of these variants were located in the AAA+ ATPase domain, while two were located in the C-terminal domain. Most affected amino acids were highly conserved in various species. A spectrum of neurological and developmental phenotypes was observed, including seizures, global developmental delay, microcephaly, and hypotonia. Thus, our findings indicate that variants of DNAH14 could lead to previously unrecognized NDDs.
- 28 April 2022
- Published by Wiley in Human Mutation
- Vol. 43 (7) , 940-949
DNAH14 variants are associated with neurodevelopmental disorders
Neurodevelopmental disorders (NDD) are complex and multifaceted diseases involving genetic and environmental sciences. Rapid developments in sequencing techniques have made it possible to identify new disease-causing genes. Our study aimed to identify novel genes associated with NDDs. Trio whole-exome sequencing was performed to evaluate potential NDD variants. We identified three unrelated patients with compound heterozygous DNAH14 variants. The detailed clinical information and genetic results of the recruited patients were obtained and systematically reviewed. Three compound heterozygous DNAH14 variants were identified as follows: c.6100C > T(p.Arg2034Ter) and c.5167A > G(p.Arg1723Gly), c.12640_12641delAA(p.Lys4214Valfs*7) and c.4811T > A(p.Leu1604Gln), andc.7615C > A(p.Pro2539Thr) and c.11578G > A(p.Gly3860Ser), including one nonsense, one frameshift, and four missense variants, which were not existent or with low minor allele frequencies based on the gnomAD database. The missense variants were assumed to be damaging or probably damaging by using multiple bioinformatics tools. Four of these variants were located in the AAA+ ATPase domain, while two were located in the C-terminal domain. Most affected amino acids were highly conserved in various species. A spectrum of neurological and developmental phenotypes was observed, including seizures, global developmental delay, microcephaly, and hypotonia. Thus, our findings indicate that variants of DNAH14 could lead to previously unrecognized NDDs.
- Open Access
- 20 May 2021
- Published by Impact Journals, LLC in Aging
- Vol. 13 (10) , 14355-14371
κ-opioid receptor stimulation alleviates rat vascular smooth muscle cell calcification via PFKFB3-lactate signaling
In the present study, the effects and mechanism of action of U50,488H (a selective κ-opioid receptor agonist) on calcification of rat vascular smooth muscle cells (VSMCs) induced by β-glycerophosphate (β-GP) were investigated. VSMCs were isolated and cultured in traditional FBS-based media. A calcification model was established in VSMCs under hyperphosphatemia and intracellular calcium contents. Alkaline phosphatase (ALP), lactate dehydrogenase (LDH), and lactate were detected in cell culture supernatants before and after treatment. Alizarin red staining was used to detect the degree of calcification of VSMCs. Expression levels of key molecules of osteogenic markers, fructose-2,6-biphosphatase 3 (PFKFB3), and proline hydroxylase 2 (PHD2), were determined using western blotting. Further, vascular calcification was induced by vitamin D3 plus nicotine in rats and isolated thoracic aortas, calcium concentration was assessed in rat aortic rings in vitro. We demonstrated that U50,488H inhibited VSMC calcification in a concentration-dependent manner. Moreover, U50,488H significantly inhibited osteogenic differentiation and ALP activity in VSMCs pretreated with β-GP. Further studies confirmed that PFKFB3 expression, LDH level, and lactate content significantly increased during calcification of VSMCs; U50,488H reversed these changes. PHD2 expression showed the opposite trend compared to PFKFB3 expression. nor-BNI or 3-PO abolished U50,488H protective effects. Besides, U50,488H inhibited VSMC calcification in rat aortic rings ex vivo. Collectively, our experiments show that κ-opioid receptor activation inhibits VSMC calcification by reducing PFKFB3 expression and lactate content, providing a potential drug target and strategy for the clinical treatment of vascular calcification.
- 20 May 2021
- Published by Impact Journals, LLC in Aging
- Vol. 13 (10) , 14355-14371
Open Accessκ-opioid receptor stimulation alleviates rat vascular smooth muscle cell calcification via PFKFB3-lactate signaling
In the present study, the effects and mechanism of action of U50,488H (a selective κ-opioid receptor agonist) on calcification of rat vascular smooth muscle cells (VSMCs) induced by β-glycerophosphate (β-GP) were investigated. VSMCs were isolated and cultured in traditional FBS-based media. A calcification model was established in VSMCs under hyperphosphatemia and intracellular calcium contents. Alkaline phosphatase (ALP), lactate dehydrogenase (LDH), and lactate were detected in cell culture supernatants before and after treatment. Alizarin red staining was used to detect the degree of calcification of VSMCs. Expression levels of key molecules of osteogenic markers, fructose-2,6-biphosphatase 3 (PFKFB3), and proline hydroxylase 2 (PHD2), were determined using western blotting. Further, vascular calcification was induced by vitamin D3 plus nicotine in rats and isolated thoracic aortas, calcium concentration was assessed in rat aortic rings in vitro. We demonstrated that U50,488H inhibited VSMC calcification in a concentration-dependent manner. Moreover, U50,488H significantly inhibited osteogenic differentiation and ALP activity in VSMCs pretreated with β-GP. Further studies confirmed that PFKFB3 expression, LDH level, and lactate content significantly increased during calcification of VSMCs; U50,488H reversed these changes. PHD2 expression showed the opposite trend compared to PFKFB3 expression. nor-BNI or 3-PO abolished U50,488H protective effects. Besides, U50,488H inhibited VSMC calcification in rat aortic rings ex vivo. Collectively, our experiments show that κ-opioid receptor activation inhibits VSMC calcification by reducing PFKFB3 expression and lactate content, providing a potential drug target and strategy for the clinical treatment of vascular calcification.
- 18 May 2018
- Published by Elsevier in European Journal of Pharmacology
- Vol. 832, 129-137
Quaternary ammonium salt of U50,488H elicits protective effects against hypoxic pulmonary hypertension
- 18 May 2018
- Published by Elsevier in European Journal of Pharmacology
- Vol. 832, 129-137
Quaternary ammonium salt of U50,488H elicits protective effects against hypoxic pulmonary hypertension